ResearchMoz

Term Life Assurance in the UK, Key Trends and Opportunities to 2017

Timetric
Published Date » 2014-01-09
No. Of Pages » 64
 
     
 
  Synopsis  
  
   
 
 
 The report provides market analysis, information and insights into the UK term life assurance business. 
 It provides a snapshot of market size and market segmentation. 
 It analyzes drivers and the outlook for the market. 
 It provides information on distribution channels for term life assurance products in the UK. 
 It rounds up deals, news and regulatory developments. 
 It provides a detailed analysis of the competitive landscape and key product features. 
 
 
   
  Summary  
     
 New business premiums in the term life assurance category grew by 7.7% in 2012, accompanied by an increase in mortgage-related protection sales. Term life assurance (excluding accelerated critical illness benefit) dominated the UK long-term protection...
Table of Content

1 Executive Summary

2 Introduction
2.1 What is this Report About?
2.2 Definitions
2.3 Methodology
2.4 Market Size
2.4.1 Level-term and decreasing-term assurance new business premiums
2.4.2 UK long-term protection market, new business regular premiums by category
2.4.3 Number of new term life assurance policies sold
2.5 Market Drivers
2.6 Market Outlook 
2.7 Distribution Channels

3 Competitive Landscape
3.1 Best Performers of 2012
3.2 Term Life Assurance – SWOT Analysis

4 Porter’s Five Forces Analysis
4.1 Bargaining Power of Suppliers: Low to Medium
4.2 Bargaining Power of Buyers: Medium to High
4.3 Barriers to Entry: Medium
4.4 Intensity of Rivalry: High
4.5 Threat of Substitutes: Medium

5 Deals and News
5.1 Aviva Launches Life Insurance Radio Advertising Campaign
5.2 Royal London Completes Co-Op Acquisitions
5.3 Aegon Improves Financial and Non-Medical Underwriting Limits for Protection
5.4 LV= Develops Corporate Life Product
5.5 Aviva Predicts Rise in Non-Advised Protection Sales As It Closes Direct Advice Arm
5.6 Ageas Launches Business Protection Product Suite
5.7 Ageas Adds ‘Life of Another’ Option to Product Range
5.8 Zurich and Guardian Launch Life Navigator Campaign

6 Regulation and Compliance
6.1 Regulatory Changes
6.1.1 Risk selection by gender has been outlawed
6.1.2 Retail Distribution Review
6.1.3 ‘I minus E’ taxation change
6.1.4 Consumer Insurance Act
6.1.5 Mortgage Market Review
6.1.6 Solvency II

7 Economic Backdrop
7.1 Real GDP Growth
7.2 Housing and Mortgage Market
7.1 Demographics

8 Company Profiles
8.1 Aegon UK Plc
8.1.1 Aegon UK Plc – key facts
8.1.2 Aegon UK Plc – main products 
8.1.3 Aegon UK Plc – main competitors
8.1.4 Aegon UK Plc – key employees
8.2 Aviva Plc – Company Overview 
8.2.1 Aviva Plc – key facts 
8.2.2 Aviva Plc – main products 
8.2.3 Aviva Plc – main competitors 
8.2.4 Aviva Plc – key employees 
8.3 Ageas UK Ltd – Company Overview
8.3.1 Ageas UK Ltd – key facts 
8.3.2 Ageas UK Ltd – main products 
8.3.3 Ageas UK Ltd – main competitors
8.3.4 Ageas UK Ltd – key employees
8.4 Friends Life Group Plc – Company Overview
8.4.1 Friends Life Group Plc – key facts
8.4.2 Friends Life Group Plc – main products 
8.4.3 Friends Life Group Plc – main competitors 
8.4.4 Friends Life Group Plc – key employees
8.5 Legal and General Group – Company Overview 
8.5.1 Legal and General Group – key facts
8.5.2 Legal and General Group – main products
8.5.3 Legal and General Group – main competitors
8.5.4 Legal and General Group – key employees 
8.6 Liverpool Victoria Group – Company Overview 
8.6.1 Liverpool Victoria Group – key facts 
8.6.2 Liverpool Victoria Group – main products 
8.6.3 Liverpool Victoria Group – main competitors
8.6.4 Liverpool Victoria Group – key employees 
8.7 Lloyds Banking Group – Company Overview 
8.7.1 Lloyds Banking Group – key facts 
8.7.2 Lloyds Banking Group – main products 
8.7.3 Lloyds Banking Group – main competitors 
8.7.4 Lloyds Banking Group – key employees 
8.8 Prudential Plc – Company Overview 
8.8.1 Prudential Plc – key facts 
8.8.2 Prudential Plc – main products 
8.8.3 Prudential Plc – main competitors 
8.8.4 Prudential Plc – key employees 
8.9 Royal London Group – Company Overview 
8.9.1 Royal London Group – key facts 
8.9.2 Royal London Group – main products 
8.9.3 Royal London Group – main competitors 
8.9.4 Royal London Group – key employees 
8.10 Zurich Financial Services Ltd – Company Overview 
8.10.1 Zurich Financial Services Ltd – key facts 
8.10.2 Zurich Financial Services Ltd – main products 
8.10.3 Zurich Financial Services Ltd – main competitors 
8.10.4 Zurich Financial Services Ltd – key employees 

9 Statistics 
9.1 Review Period 
9.2 Forecast Period 

10 Appendix 
10.1 Methodology 
10.2 Contact Timetric 
10.3 About Timetric 
10.4 Timetric’s Services 
10.5 Disclaimer

List of Tables


Table 1: Insurance Industry Definitions 
Table 2: Term Life Assurance – SWOT Analysis
Table 3: Recent and Upcoming Regulatory Changes
Table 4: Aegon UK Plc, Key Facts 
Table 5: Aegon UK Plc, Main Products
Table 6: Aegon UK Plc, Key Employees 
Table 7: Aviva Plc, Key Facts 
Table 8: Aviva Plc, Main Products 
Table 9: Aviva Plc, Key Employees 
Table 10: Ageas UK Ltd, Key Facts 
Table 11: Ageas UK Ltd, Main Products 
Table 12: Ageas UK Ltd, Key Employees 
Table 13: Friends Life Group Plc, Key Facts 
Table 14: Friends Life Group Plc, Main Products 
Table 15: Friends Life Group Plc, Key Employees 
Table 16: Legal and General Group, Key Facts 
Table 17: Legal and General Group, Main Products 
Table 18: Legal and General Group, Key Employees 
Table 19: Liverpool Victoria Group, Key Facts 
Table 20: Liverpool Victoria Group, Main Products 
Table 21: Liverpool Victoria Group, Key Employees 
Table 22: Lloyds Banking Group, Key Facts 
Table 23: Lloyds Banking Group, Main Products 
Table 24: Lloyds Banking Group, Key Employees 
Table 25: Prudential Plc, Key Facts 
Table 26: Prudential Plc, Main Products 
Table 27: Prudential Plc, Key Employees
Table 28: Royal London Group, Key Facts
Table 29: Royal London Group, Main Products
Table 30: Royal London Group, Key Employees
Table 31: Zurich Financial Services Ltd, Key Facts
Table 32: Zurich Financial Services Ltd, Main Products
Table 33: Zurich Financial Services Ltd, Key Employees 
Table 34: UK Term Life Assurance – New Business Premiums (GBP Thousand), 2008–2012 
Table 35: UK Term Life Assurance – New Business Premiums (GBP Thousand), 2013–2017

List of Figures


Figure 1: UK Term Life Assurance (Excluding Accelerated CI) – Total New Business Premiums (GBP Million), 2008–2012 
Figure 3: UK Long-Term Protection Market – New Business Regular Premiums by Category (GBP Million), 2008–2012 
Figure 4: Number of New Term Life Policies Sold by FSA-Regulated Life Insurers, Excluding Accelerated CI (Thousands), 2008–2012 
Figure 5: New Business Premiums for UK Term Life Assurance, Excluding Accelerated CI (GBP Million), 2013–2017 
Figure 6: Top 10 Term Life Assurance Providers Based on Total New Business Premium (Excluding Accelerated CI), 2012 (%) 
Figure 7: UK Term Life Assurance – Five Forces Analysis 
Figure 8: The UK’s Insurance Regulatory Framework 
Figure 9: Real GDP Growth (%), 2008–2017 
Figure 10: Simple Average House Prices in the UK (GBP), 1991–2012 
Figure 11: Number of First-Time Homebuyers (Thousands), 2002–2012 
Figure 12: Total Gross Mortgage Lending (GBP Million), 2002–2012 
Figure 13: Growing and Aging Population, 1995–2012 
Figure 14: UK Population Aged Over 65 (%), 1995–2017 
Figure 15: UK Overall Life Expectancy (Years), 1995–2017 
Figure 16: Improving Living Standards in the UK (GBP Thousand), 1997–2011 

Upcoming Reports:

Single-Use Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Over the past two decades, single-use bioreactors or disposable bioreactors have been in use in pharmaceutical industry that consists of a disposable bag instead of typical culture vessel made up of stainless steel or glass. On the other hand the disposable bag is usually made of three layers of plastic to offer mechanical stability and act as a gas barrier. The single-use bioreactor has several advantages over conventional bioreactors. Pharmaceutical companies usually produce different drugs using the same facility without compromising the quality and operate in various consecutive...
Antipsychotic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Antipsychotics are drugs used in the treatment of brain disorders such as schizophrenia, bipolar disorder, and severe depression. According to the New York Times, antipsychotics are one of the largest types of prescribed drugs in the United States with over 3.1 million Americans accounting for a market worth USD 18 billion in 2011 itself. Global estimates suggest that over 1.25% of the global population suffers from psychosis and related disorders. This brings a market of about 7.5 million people suffering from combined disorders of schizophrenia, bipolar disorder, dementia,...
Digital Photography Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Marketing is sharpening its focus on the ‘D’ word whether it is the Digital market or Digital photography market. Just 20 years ago, people were considerably less aware about this market as well as the charming opportunities that it could provide.  The market for digital photography is estimated at USD 82.6 billion by the year 2016, registering a growth of 5.9% annually. The digital photography market with its complementary products like cameras, lenses, printers, storage cards, digital photo frames, and photo editing software, accounts for more than...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Hitachi Readies New Suite of Driving Systems
Oct 16, 2014  
Japan’s Hitachi Automotive Systems is all set to unveil a line of innovative autonomous driving technologies as the trend of high-tech and automotive electronics takes the industry by storm. The suite of technologies were unveiled in northern Japan last week and included features such as no-hands self-parking, vehicle stability control in electric automobiles, precrash braking, and...
Canadas Agreement on Waste-Water Treatment Boosts Indias PM Pet Clean Ganga Project
Oct 16, 2014  
In 2008, Canada and India adopted a bilateral science and technology collaboration agreement for Scientific and Technological Cooperation.  The pet Clean Ganga project led by the Indian Prime Minister Narendra Modi has received a confident boost with an agreement earlier on Wednesday. The agreement is all about cleaning up the most heavily used river in the world between Canada...
China Sends Experimental Ebola Drugs to Aid Workers, to Increase Supply if Found Effective
Oct 16, 2014  
An experimental Ebola drug has been sent to Africa for use by Chinese aid worker by a Chinese drug manufacturer. The company is plans to undertake clinical trials of the drug to combat the deadly Ebola outbreak in West Africa that has claimed more than 4000 lives so far. Several thousand doses of the drug JK-05, manufactured by Sihuan Pharmaceutical Holdings Group Ltd, have been...
Broccoli Based Chemical Gives Hope For Treating Autism
Oct 15, 2014  
According to the inferences derived from a small scale clinical trial, the chemical that is extracted from the sprouts of broccoli possess certain anti-cancerous properties. Moreover, this chemical may be able to even treat behavioral symptoms in those suffering from autism spectrum disorders. This research study was carried out by the scientists of Johns Hopkins University School of Medicine...
Toyota China to Recall Crown Sedans Due to Leaking Brake Fluid Issue
Oct 15, 2014  
Joining the global wave of automobile recalls, Toyota has announced its decision to recall 93,700 cars from the Chinese market to fix an issue regarding leaking brake fluid, Chinese quality watchdog has informed.  Tianjin FAW Toyota Motor Co, the Chinese subsidiary of Toyota Motor Corp., will recall the Crown model sedans manufactured by it between 1st December 2009 and 14th June 2012....